1)  complement membrane attack complex
					 
	
					
				
				 
	
					
				补体膜攻击复合物
				1.
					Preparation and identification of monoclonal antibody against neoantigens of human complement membrane attack complex;
						
						抗人补体膜攻击复合物新抗原单克隆抗体的制备及鉴定
					
					2)  membrane attack complex
					 
	
					
				
				 
	
					
				补体膜攻击复合物
				1.
					Effect of membrane attack complex assembling on synthesis of collagen type Ⅳ in renal tubular epithelial cells in vitro;
						
						体外组装补体膜攻击复合物对肾小管上皮细胞Ⅳ型胶原合成的影响
					2.
					Change of  free calcium ion concentration in cytoplasm of vascular endothelial cells induced  by complement membrane attack complex;
						
						补体膜攻击复合物刺激血管内皮细胞胞浆游离钙离子浓度的变化
					
					3)  SC5b-9
					 
	
					
				
				 
	
					
				补体膜攻击复合体
				1.
					Methods 143 blood specimens from 45 normal controls, 56 nephritis patients and 42 patients with nephrotic syndrome were studied to determine the contents of SC5b-9, CIC and CH50 and the titers of ANA and AdsDNA antibodies by using PEG precipitation reaction, hemolytic assay, sandwich ELISA and Dot-IGSS respectively.
						
						目的 探讨循环免疫复合物 (CIC)、补体溶血总活性 (CH5 0 )、补体膜攻击复合体 (SC5b - 9)、抗核抗体(ANA)和抗双链DNA(AdsDNA)抗体在肾炎和肾病综合征患者病变中的临床意义。
					
					4)  C5b-9
					 
	
					
				
				 
	
					
				补体攻膜复合物C5b-9
				1.
					Study the effect of C5b-9 to peripheral blood dendritic cells;
					 
					
						
						 
					
						补体攻膜复合物C5b-9对人外周血树突状细胞的作用研究
					
					6)  multi-step attack
					 
	
					
				
				 
	
					
				复合攻击
				1.
					Forecast algorithm for multi-step attack based on attack intention;
					 
					
						
						 
					
						基于攻击意图的复合攻击预测方法研究
					2.
					They are multi-step attacks which are composed by a set of attack actions.
					 
					
						
						 
					
						通过对复合攻击模式的深入研究,提出了一种基于攻击意图检测和预测复合攻击的方法。
					3.
					The multi-step attack is one of the primary forms of the current intrusions.
					 
					
						
						 
					
						复合攻击是网络入侵的主要形式之一。
					补充资料:补体复合物
		补体复合物
complement compound
在正常的生理情况下,补体各成分除C1q外,在体液中皆呈无活性状态,当受某种激活因子的作用,补体即按一定顺序活化。补体从C1开始活化的经典途径需与抗原抗体综合后暴露出的抗体上的Fc段结合;从C3开始活化的旁路途径,需与聚合的IgG、IgA和IgE类抗体及高分子多糖相结合。总之,在其活化过程中,不断组成新的中间复合物,具有不同的酶活性,并表现出不同的生物学活性。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
	参考词条